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Alcoholic liver disease (ALD) is a major global health problem. Chronic alcohol use results in inflammation and fatty liver, and in
some cases, it leads to fibrosis and cirrhosis or hepatocellular carcinoma. Increased proinflammatory cytokines, particularly TNF
alpha, play a central role in the pathogenesis of ALD. TNF alpha is tightly regulated at transcriptional and posttranscriptional levels.
Recently, microRNAs (miRNAs) have been shown to modulate gene functions. The role of miRNAs in ALD is getting attention,
and recent studies suggest that alcohol modulates miRNAs. Recently, we showed that alcohol induces miR-155 expression both
in vitro (RAW 264.7 macrophage) and in vivo (Kupﬀer cells, KCs of alcohol-fed mice). Induction of miR-155 contributed to
increased TNF alpha production and to the sensitization of KCs to produce more TNF alpha in response to LPS. In this paper, we
summarize the current knowledge of miRNAs in ALD and also report increased expression of miR-155 and miR-132 in the total
liver as well as in isolated hepatocytes and KCs of alcohol-fed mice. Our novel finding of the alcohol-induced increase of miRNAs
in hepatocytes and KCs after alcohol feeding provides further insight into the evolving knowledge regarding the role of miRNAs in
ALD.
1. Introduction
MicroRNAs (miRNAs) are 20–22 nucleotides long noncod-
ing RNAs that were first described in 1993 [1]. MiRNAs
play a central role in diverse cellular processes including
development, immunity, cell-cycle control, metabolism, viral
or bacterial disease, stem-cell diﬀerentiation, and oncogen-
esis [2–4]. In general, miRNAs are transcribed from RNA
polymerase II or III in the nucleus and transported to the
cytoplasm, where they are processed into mature miRNAs
[4]. Mature miRNAs can target hundreds of genes by either
binding to the 3′ or 5′ untranslated (UTR) region of mRNA
[4]. Emerging evidence suggests that miRNAs not only
target mRNAs but also they are capable of modulating
transcription and methylation processes [5–7]. Moreover,
not only the sense strand (miRNA) of mature miRNA
modulates gene function, but also the antisense strand (star
form; ∗) plays an important role in the miRNA regulatory
network [8]. However, the biological significance of the
antisense strand (star form) is largely unknown but is slowly
getting attention. In a short time, miRNA research has
received tremendous attention due to their fine-tuning roles
in almost all biological pathways. Moreover, disease-specific
tissue miRNA signatures have been identified in various
etiologies such as hepatocellular carcinoma (HCC), hepatitis
C virus (HCV), hepatitis B virus (HBV), cardiac disease,
neuroinflammation, rheumatic arthritis (RA), and various
cancers [3, 9–14]. In this paper, we highlight the emerging
roles of miRNAs in alcoholic liver disease.
1.1. MiRNA in Innate Immune Response. Innate immunity
is the first line of host defense against foreign pathogens
and also in response to damaged self (endogenous danger
signals). Toll-like receptors (TLRs) are the most widely stud-
ied danger signal sensors. MiRNAs have been implicated in
various immune responses and are believed to be essential
regulators of these processes [15]. The number of miRNAs
involved in immune responses is growing, and among them,
miR-155, -146a, -125b, -132, -9, -212 and -181, are the
key players and are elegantly reviewed in [16, 17]. The
inflammation-related miRNAs deserve attention in ALD, as
the activation of the innate immune system is a hallmark of
alcoholic steatohepatitis.
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2. MiRNA in Alcoholic Liver Disease
2.1. Alcoholic Liver Disease (ALD). Alcoholic liver disease
(ALD) is a global health-related problem, which contributes
significantly to liver-related mortality. Increased inflamma-
tion and fat accumulation are the hallmarks of ALD. The
progression of ALD involves a complex network of signaling
molecules and chronic alcohol abuse in some cases leads
to liver cirrhosis [18]. Alcohol alone or its metabolites (ac-
etaldehyde) act on multiple signaling pathways and result
in increased intestine permeability and ROS generation
[19, 20]. Increased gut permeability is associated with
translocation of bacteria and bacterial products into the
lumen of the intestine, which results in the imbalance of
intestine homeostasis [20]. LPS is a major component of
a Gram-negative bacterial cell wall, and it is detoxified in
the liver via both parenchymal and nonparenchymal cells
[21, 22]. It is believed that increased LPS in the circulation
disrupts the liver homeostasis, resulting in Kupﬀer cell
(KC; liver macrophages) activation. Upon activation, KCs
produce TNF alpha, which then induces the activation of
other signaling cascades to amplify the inflammation. TNF
alpha-induced inflammation is more prevalent in alcoholic
hepatitis [23]. The role of the LPS/TLR4 axis has been
appreciated in ALD, since TLR4 KO mice have been shown
to be protected from liver damage in a mouse model of ALD
[24].
2.2. MiRNA Profiling in the Livers of Alcohol-Fed Mice.
Alcohol has been shown to modulate the epigenetic factors
in various organs including liver and brain and was reviewed
recently [25]. As alcohol exerts epigenetic eﬀects, it is con-
ceivable that alcohol might target miRNAs to regulate gene
functions. To date, there are very few studies related to
the roles of miRNAs in ALD. Previously, our laboratory
demonstrated the diﬀerential expression of some miRNAs
in the livers of alcohol-fed mice by microarray analysis
[26]. MiR-27b, miR-214, miR-199a-3p, miR-182, miR-183,
miR-200a, and miR-322 were found to be downregulated,
whereas miR-705 and miR-1224 were increased after 4 weeks
of alcohol feeding in mice [26]. However, the physiological
relevance of these miRNAs in ALD has yet to be determined.
2.3. The Role of miRNA in Alcohol-Induced Intestinal Perme-
ability. Alcohol and its metabolites are known to increase
intestinal permeability [27]. In the past, various signaling
molecules and transcription factors were reported to be
involved in alcohol-mediated intestinal permeability. Re-
cently, miR-212 has been identified as a new player and
implicated in alcohol-induced intestinal permeability, where
it targets a major tight junction protein, Zonula occludens 1
(ZO-1) [28]. ZO-1 plays an essential role in the regulation of
intestinal permeability. Induction of miR-212 and decrease
in ZO-1 protein were observed both in colon biopsy samples
from patients with ALD and in alcohol-treated CaCO-2 cells
[28].
Recently, miR-29a and miR-122a were reported to mod-
ulate intestinal membrane permeability. MiR-29a regulates
intestinal membrane permeability in patients with irritable
bowel syndrome (IBS) [29]. Increased expression of miR-
29a was found in blood microvesicles, small bowel, and
colon tissues of IBS patients. MiR-29a targets the glutamine
synthetase gene (GLUL), which in turn regulates intestinal
membrane permeability [29]. MiR-122a was found to target
occludin (a transmembrane tight junction protein) both
in Caco-2 cells and mice enterocytes and hence plays an
important role in regulating intestinal permeability [30]. The
potential role of these miRNAs in alcohol-induced intestinal
permeability is yet to be determined.
2.4. Potential Role of miRNA in Alcohol-Mediated Oxidative
Stress. Not only does increased circulating endotoxin play
a crucial role in ALD, but also increased reactive oxygen
species (ROS and oxidative stress) production contributes to
the pathogenesis of ALD [20, 27]. In agreement with this,
NADPH oxidase is reported as a major source of oxidants
in ALD, and mice deficient in this oxidase (p47phox−/−) were
protected from early alcohol-induced liver injury [31]. In
general, the potential role of miRNAs in oxidative stress-
mediated etiologies is emerging. In line with this, miR-
27a∗, miR-27b∗, miR-29b∗, miR-24-2∗, and miR-21∗ were
reported to be diﬀerentially expressed in response to H2O2-
induced oxidative stress in RAW 264.7 macrophage [32].
Furthermore, overexpression of miR-27b∗ suppressed LPS-
induced activation of NF-κB [32]. These data suggest that
macrophage function can be regulated by oxidative stress-
responsive miRNAs via modulating the NF-κB pathway [32].
Interestingly, in this study, only the star form of mature
miRNA was found to play a role in H2O2-induced oxidative
stress. To our knowledge, there are no studies indicating the
direct involvement of miRNAs in alcohol-induced oxidative
stress.
Alcohol has been shown to downregulate miR-199 in
rat liver sinusoidal endothelial cells (LSECs) and human en-
dothelial cells [33]. Decreased miR-199 was associated with
increasedmRNA expression of endothelin-1 (ET-1) and hyp-
oxia-inducible factor-1α (HIF-1α) [33]. Authors concluded
that alcohol-induced ET-1 likely contributes to inflammation
in patients with cirrhosis.
2.5. Role of miRNA-155 in Kupﬀer Cell Activation in Alcoholic
Liver Disease. Previous studies from our laboratory and
others have shown increased TNF alpha in vivo and in
vitro alcohol models [34, 35]. Moreover, increased TNF
alpha was found in patients with alcoholic hepatitis [23].
Previously, alcohol has been shown to regulate TNF alpha
mRNA stability in RAW 264.7 macrophage and KCs [35].
Furthermore, miRNAs modulate gene expression both at
posttranscriptional and translational levels [3, 5, 6]. Recently,
we have shown that prolonged alcohol exposure induces
miR-155 in RAW264.7 macrophage and KCs [34]. However,
no changes were found in the expression of miR-146a and
-125b, which are also involved in immune responses. This
observation suggests that alcohol particularly targets miR-
155 [34]. We further showed that miR-155 expression corre-
lates with TNF alpha levels. Functionally, miR-155 regulates
TNF alpha mRNA stability, and thereby contributes to
increased TNF alpha in KCs of alcohol-fed mice. TNF alpha
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is tightly regulated both at transcriptional and posttranscrip-
tional levels. Posttranscriptional regulation of TNF alpha
includes mRNA stability, polyadenylation, and translational
initiation, which target adenine and uridine- (AU-) rich
elements (AREs) in its 3UTR [36]. Trans-acting factors such
as HuR, tristetraprolin (TTP), and TIA-1, bind to 3UTR of
TNF alpha and modulate its expression either by stabilizing
or destabilizing its transcripts [36]. Interestingly, chronic al-
cohol has been shown to increase TNF alpha mRNA stability
via HuR protein [35, 37, 38]. As our results indicated
that miR-155 enhances TNF alpha transcript stability, it is
plausible to suggest that miR-155 might be exerting its eﬀect
via targeting HuR or other trans-acting factors. Hence, our
study directly or indirectly implicates the role of miR-155 in
TNF alpha regulation. Given the fact that one miRNA can
regulate multiple genes of a pathway; it is likely that miR-155
might regulate other genes, which are directly or indirectly
involved in TNF alpha regulation.
2.6. Induction of miRNA in the Livers of Alcohol-Fed Mice.
As described above, previously, we found induction of miR-
155 in alcohol-exposed RAW264.7 macrophage and KCs
of alcohol-fed animals [34]. Here, we examined the liver
expression of other miRNA including miR-132, -125b, and
-146a which also regulate various immune responses. MiR-
132 was shown to play a role in neuroinflammation [39]
and also regulates innate antiviral immunity, where it targets
the p300 transcriptional coactivator [40]. However, the role
of miR-132 in the alcohol-mediated TLR response is yet
to be elucidated; therefore, in this study, we determined
the eﬀect of alcohol on miR-132. MiR-146a is linked with
endotoxin tolerance, where it regulates IRAK-1 and TRAF-
6 and acts as a negative regulator of TLR4 signaling [41],
whereas miR-125b limits TNF alpha production in RAW
264.7 macrophage [42].
Among the miRNAs tested, we found significant induc-
tion of miR-132 in the livers of alcohol-fed mice (Figure 1).
As expected, a significant increase in miR-155 was also
observed in the livers of alcohol-fed mice (Figure 1), and
this result was consistent with our previous report [21].
Contrary to this observation, no significant changes were
observed in miR-125b and -146a expression (Figure 1). The
mice used in the study were housed and cared for as per
animal protocols approved by the Institutional Animal Use
and Care Committee of the University of Massachusetts
Medical School.
2.7. Increase in miR-155 in Hepatocytes of Alcohol-Fed Mice.
Because of the crucial role of miR-155 in inflammation,
most studies are focused on its role in immune cells such
as monocytes, macrophages, dendritic cells, and T cells (re-
viewed in [16, 17, 41]). Induction of miR-155 has been
reported in various inflammatory-related diseases such as
RA, neuro- or autoimmune-inflammation and various can-
cers [43–46]. The concept of cell-specific eﬀects of miRNA
is emerging, and reports showing the role of immune-
related miRNAs in hepatocytes are sparse. Recent studies
suggest that hepatocytes do respond to LPS-induced TLR
signaling and express functional NOD1 and 2 receptors [47].
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Figure 1: Increased expression of miR-155 and miR-132 in the
livers of alcohol-fed mice. C57BL/6 eight-week-old female mice
(n = 6/group) were fed with Lieber-Decarli diet either containing
5% alcohol (ethanol-fed) or isocaloric liquid diet (pair-fed) for 4
weeks. After 4 weeks, the livers were isolated and stored in RNA
later (Qiagen) for RNA analysis at −80◦C. Total RNA from livers
was isolated using the miRNeasy kit (Qiagen), and quantification
of miRNAs was carried out by TaqMan miRNA assays (Applied
Biosystems). The data were normalized to SnoRNA202 (endoge-
nous control) and shown as fold change over the pair-fed control
group. Data represent mean values ± S.E.M. Statistical significance
was determined using T-test (two-tailed).
Therefore, next, we examined the eﬀect of alcohol onmiRNA
expression in hepatocytes, which are the predominant liver-
cell population.
Hepatocytes were isolated from mice fed with Lieber-
DeCalri diet either with 5% alcohol (ethanol-fed) or isoca-
loric diet (pair-fed) for 4 weeks [34]. Hepatocytes isolation
was performed with the method described earlier by our
group [24]. Total RNA was isolated with the miRNeasy kit
(Qiagen) and subjected to miRNA analysis as described
previously [34]. Briefly, TaqMan miRNA assay (Applied Bi-
osystems) was used, and snoRNA202 was used as internal
control to normalize the technical variations between the
samples. Fold change was calculated in comparison to pair-
fed mice.
Interestingly, we found increased expression of miR-155
in hepatocytes of alcohol-fedmice compared to pair-fedmice
(Figure 2). To our best knowledge, this is the first study
reporting the induction of miR-155 in hepatocytes after
alcohol feeding. No obvious changes were observed in miR-
146a expression and there was minimal increase in miR-132
expression in hepatocytes of alcohol-fed mice (Figure 2). In
contrast, expression of miR-125b was found to be downreg-
ulated in hepatocytes after alcohol feeding (Figure 2). The
physiological relevance of alcohol-induced miR-155 in hepa-
tocytes is the subject of ongoing investigation.
In diet-induced (methyl-deficient diet) nonalcoholic
steaohepatitis, increased miR-155 was associated with de-
creased levels of C/EBP-β and SOCS1 proteins [48]. In vitro
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Figure 2: Induction of miR-155 in hepatocytes of alcohol-fed mice.
Hepatocytes were isolated from the mice (n = 5-6) after 4 weeks
of feeding. Briefly, the livers were perfused, followed by digestion.
Parenchymal cells (hepatocytes) were collected after low-speed
centrifugation, washed, andwere plated onto 6-well collagen-coated
plates (BD-Biosciences). After 3 h, floating cells were removed,
and adherent cells were washed twice with PBS and lysed in
QIAzole (Qiagen). Total RNA was isolated and miRNA expression
was quantified by TaqMan miRNA assays (Applied Biosystems).
The data were normalized to SnoRNA202 (endogenous control)
and shown as the fold change over the pair-fed control group.
Data represent mean values ± S.E.M. Statistical significance was
determined using non-parametric Mann-Whitney test.
overexpression of miR-155 in mouse primary hepatocytes
resulted in a decreased level of C/EBP-β and SOCS1 proteins
[48]. Both C/EBP-β and SOCS1 are tumor suppressors [49]
and often downregulated in hepatocellular carcinomas and
hepatoblastomas [50]. The relevance of C/EBP-β and SOCS1
could be translated to ALD due to the fact that SOCS1 not
only acts as a tumor suppressor, but also is a negative
regulator of LPS signaling, while chronic alcohol use results
in increased inflammatory cytokine production. Moreover,
SOCS1 is also an important mediator of cellular oxidative
stress [51].
C/EBP-β regulates several hepatic genes such as catalase
and methionine adenosyltransferase 1a that are involved in
regulation of oxidative stress [52, 53]. As oxidative stress
plays an essential role in the pathogenesis of ALD, it is reason-
able to argue that increased miR-155 observed in hepatocytes
of alcohol-fed mice might contribute to increased oxidative
stress via the regulation of genes involved in oxidative stress
pathways. However, further studies are needed to prove this
speculation in ALD.
More recently, miR-155 has been demonstrated to play
a role in antiviral immunity against HBV infection in
human hepatoma cells, HepG2 [54]. Overexpression of miR-
155 resulted in decreased SOCS1, which enhances STAT 1
and 3 phosphorylation [54]. Increased expression of sev-
eral interferon-inducible antiviral genes was observed after
ectopic expression ofmiR-155 in human hepatoma cells [54].
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Figure 3: Upregulation of miR-155 and -132 in Kupﬀer cells of
alcohol-fed mice. Kupﬀer cells were isolated either from pair-fed
or alcohol-fed mice (n = 12–14/group, cells from two mice were
pooled) after 4 weeks of feeding. Cells were plated and after 2 h
of incubation nonadherent cells were removed. Fresh medium was
added to the adherent, and they were rested overnight. Next day,
cells were washed with PBS and lysed with QIAzole (Qiagen). Total
RNA isolated using the miRNeasy kit was used quantify miRNA as
described above. Data represent mean values ± S.E.M. Statistical
significance was determined using T-test (two-tailed).
It was concluded that miR-155 acts as a positive regulator of
JAK/STAT signaling via targeting SOCS1 and hence increases
the expression of some IFN-inducible antiviral genes such as
ISG15 and MxA [54].
In this study, we also found decreased miR-125b in
hepatocytes of alcohol-fed mice (Figure 2). Downregulation
ofmiR-125b has been reported inHCC and is associated with
increased placenta growth factor (PIGF) [55]. However, the
physiological relevance of miR-125b downregulation in ALD
has yet to be explored.
2.8. Increase of miR-155 and miR-132 in Kupﬀer Cells of
Alcohol-Fed Mice. Next, we examined the expression of
miRNAs in KCs of alcohol-fed mice. KCs were isolated as
described earlier [34]. We focused our study on miR-155 and
miR-132, as the expression of these miRNAs was increased
in the livers after alcohol feeding (Figure 1). Interestingly,
we not only observed a significant increase in miR-155,
which was consistent with our previous report [34], but
also induction of miR-132 in the KCs of alcohol-fed mice
(Figure 3).
Induction of miR-132 in alcohol-fed mice is interesting,
as the role of this miRNA in innate immunity is not
much appreciated. Recently, miR-132 was shown to play a
role in the innate viral response, where it targets p300, a
transcriptional coactivator [40]. Chronic alcohol use predis-
poses individuals to infections (bacterial and viral), and the
induction ofmiR-132 after alcohol feeding is of great interest.
We also found a modest increase of miR-132 in hepatocytes
of alcohol-fed mice. The physiological relevance of miR-132
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in the alcohol-mediated immune response is currently under
investigation.
Collectively, our results indicate an increase in miR-155
in diﬀerent cell populations of the liver after alcohol feeding.
It is most likely that the induction of miR-155 we observed in
hepatocytes of alcohol-fed mice is involved in both LPS and
oxidative stress signaling pathways, and hence contributes to
the progression of ALD.
3. Conclusions
Our understanding of the role of miRNAs in liver disease
is expanding, and the current studies suggest that miRNAs
play a crucial role in alcoholic liver disease. However, in-
depth understanding of association of miRNAs with their
cell-specific roles in ALD is yet to be explored. We not
only showed induction of miR-155, but also miR-132 in the
livers and KCs of alcohol-fed mice. Furthermore, an increase
in miR-155 was also observed in hepatocytes of alcohol-
fed mice. The cell-specific eﬀect of these miRNAs in ALD
deserves further investigation.
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